Tele-Self CBTI Trial
Tele-Self CBTI
Provider Supported Self-Help Cognitive Behavioral Therapy for Insomnia (Tele-Self-CBTI)
2 other identifiers
interventional
178
1 country
1
Brief Summary
Insomnia is one of the most common complaints among service-members and Veterans of recent military conflicts. Insomnia has been shown to play a causal role in mental health, hypertension, obesity, and other health conditions, increasing risk for all-cause mortality. Cognitive-Behavioral Therapy for Insomnia (CBTI) produces both short-term and sustained resolution of insomnia with fewer adverse side effects than medications, but access to behavioral sleep medicine expertise within the VA is very limited. This study compares Tele-Self CBTI to Health Education Control for improved insomnia severity among treatment-seeking Veterans with Insomnia. In this study, 200 participants will be randomized with a 50/50 chance to either Tele-Self CBTI or a Health Education Control condition. Eligible participants are Veterans who are: a) prescribed sleep medications; b) diagnosed with insomnia; and/or c) referred for clinic-based CBTI (but not yet treated) for insomnia. Participants will be identified using electronic health records (EHR) and telephone interviews. Participants' sleep will be assessed at three time points, at Baseline, 8 weeks and 6 months after Baseline. The Tele-Self CBTi intervention is comprised of two treatment components: 1) self-directed treatment via weekly readings from a treatment manual, and 2) weekly telephone-based nurse support contacts across a 8 week intervention period. Participants randomized to Tele-Self CBTI will complete 6 weekly readings in addition to having 6 weekly telephone contacts with a study nurse; each call lasting approximately 20 minutes. Patients randomized to Health Education Control (HEC) will receive a health education manual on 6 health topics. They will also complete 6 weekly readings from the HEC manual and receive 6 weekly telephone contacts from a study nurse. All participants will continue to receive usual medical care while participating in the study. Following completion of this 6 month study, participants randomized to HEC and interested in additional help for their sleep will be referred to the Durham VA Behavioral Sleep Medicine Clinic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2018
CompletedFirst Posted
Study publicly available on registry
November 1, 2018
CompletedStudy Start
First participant enrolled
October 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedResults Posted
Study results publicly available
September 24, 2024
CompletedSeptember 24, 2024
September 1, 2024
3.2 years
October 30, 2018
December 14, 2023
September 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insomnia Severity
Insomnia Severity Index (ISI): The ISI is recommended as the standard for self-reported insomnia symptoms, and will be used as the primary outcome measure. The ISI is a 7-item questionnaire providing a global measure of perceived insomnia severity. Each item is rated on a 5-point Likert scale and the total score ranges from 0 (no reported symptoms) to 28 (highest insomnia severity symptoms). The following guidelines are recommended for interpreting the total score: 0-7 (no clinical insomnia), 8-14 (sub threshold insomnia), 15-21 (insomnia of moderate severity), and 22-28 (severe insomnia). In clinical samples, a cut off score of 11 was shown to have the greatest sensitivity and specificity for correctly identifying study participants meeting criteria for insomnia diagnosis.
Baseline to 8 weeks
Secondary Outcomes (6)
Subjective Sleep Onset Latency (SOL)
Baseline to 8 week
Subjective Wake After Sleep Onset (WASO)
Baseline to 8 week
Subjective Sleep Efficiency (SE)
Baseline to 8 week
Objective Wake After Sleep Onset
Baseline to 8 week
Objective Total Sleep Time (TST)
Baseline to 8 week
- +1 more secondary outcomes
Study Arms (2)
Tele-Self CBTI
EXPERIMENTALTele-Self CBTi is a telephone-based CBT insomnia intervention
Health Education Control
ACTIVE COMPARATORThe Health Education is an active control arm
Interventions
The Tele-Self CBTI intervention is comprised of two treatment components: 1) self-directed treatment via weekly readings from a treatment manual, and 2) weekly telephone-based nurse support contacts across a 8 week intervention period. Participants have 8 weeks to complete 6 study-related phone calls
The Health Education Control condition is comprised of two components: 1) weekly reading from a health education manual, and 2) weekly telephone-based nurse support contacts across a 8 week period. At the end of the study, participants in the Health Education arm will be offered assistance for their sleep complaints, as needed, through the Durham Behavioral Sleep Medicine clinic.
Eligibility Criteria
You may qualify if:
- Meets diagnostic criteria for Insomnia Disorder
- Receives care through the Durham VA Health Care System (HCS) catchment area
You may not qualify if:
- Severe Obstructive Sleep Apnea with treatment non-adherence
- Unstable co-morbid sleep disorder determined via chart review
- e.g., rule out for Narcolepsy, rule out for Shift Work Disorder
- Current or prior participation in Cognitive Behavioral Therapy for Insomnia (CBTI)
- Excessive daytime sleepiness
- Nighttime or rotating shift work within the last year
- Psychotic disorder diagnosis
- Bipolar disorder diagnosis
- Recreational substance use
- Current alcohol abuse
- Severe depression or suicidality
- Dementia diagnosis
- Cognitive impairment
- Epilepsy diagnosis
- Seizure disorder diagnosis
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Durham VA Medical Center, Durham, NC
Durham, North Carolina, 27705-3875, United States
Related Publications (3)
Ulmer CS, McCant F, Stechuchak KM, Olsen M, Bosworth HB. Prevalence of insomnia disorder and sleep apnea in a sample of veterans at risk for cardiovascular disease. J Clin Sleep Med. 2021 Jul 1;17(7):1441-1446. doi: 10.5664/jcsm.9228.
PMID: 33688827BACKGROUNDUlmer CS, Bosworth HB, Zervakis J, Goodwin K, Gentry P, Rose C, Jeffreys AS, Olsen MK, Weidenbacher HJ, Beckham JC, Voils CI. Provider-supported self-management cognitive behavioral therapy for insomnia (Tele-Self CBTi): Protocol for a randomized controlled trial. Contemp Clin Trials. 2023 Feb;125:107060. doi: 10.1016/j.cct.2022.107060. Epub 2022 Dec 22.
PMID: 36567058RESULTUlmer CS, Voils CI, Jeffreys AS, Olsen M, Zervakis J, Goodwin K, Gentry P, Rose C, Weidenbacher HJ, Beckham JC, Bosworth HB. Nurse-Supported Self-Directed Cognitive Behavioral Therapy for Insomnia: A Randomized Clinical Trial. JAMA Intern Med. 2024 Nov 1;184(11):1356-1364. doi: 10.1001/jamainternmed.2024.4419.
PMID: 39250131RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Limitations of the study include not achieving equal contact time across conditions and having lower retention of active arm than control condition participants.
Results Point of Contact
- Title
- Jennifer Zervakis
- Organization
- Department of Veteran Affairs ADAPT
Study Officials
- PRINCIPAL INVESTIGATOR
Christi S. Ulmer, PhD
Durham VA Medical Center, Durham, NC
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2018
First Posted
November 1, 2018
Study Start
October 4, 2019
Primary Completion
December 16, 2022
Study Completion
April 1, 2023
Last Updated
September 24, 2024
Results First Posted
September 24, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share